Filing search / Cidara Therapeutics, Inc. / "Pandemic"

8-K

EX-99.1

CDTX Cidara Therapeutics, Inc.

6 Mar 25

Cidara Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2024 Financial Results

4:40pm

DFC candidate, CD388, is a long-acting antiviral designed to achieve universal prevention of seasonal and pandemic influenza with a single dose

424B3

CDTX Cidara Therapeutics, Inc.

2 Jan 25

Prospectus supplement

4:02pm

universal prevention and treatment of seasonal and pandemic influenza. Private Placement On November 20, 2024, we entered into a securities purchase … to develop CD388 as a universal preventative against seasonal and pandemic influenza A and B, beginning with the CD388 Phase 2b NAVIGATE study that we

8-K

EX-99.1

CDTX Cidara Therapeutics, Inc.

26 Nov 24

Cidara Therapeutics Announces $105 Million Private Placement

4:12pm

antiviral designed to achieve universal prevention of seasonal and pandemic influenza with a single dose by directly inhibiting viral proliferation

8-K

EX-99.1

0kmk 6k25

7 Nov 24

Cidara Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results

4:13pm

8-K

EX-99.1

vx4fgnqefbx6y

13 Aug 24

Cidara Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results

4:19pm

424B3

smm1hpy02amo

31 Jul 24

Prospectus supplement

5:25pm

8-K

EX-99.1

d4a8sbo

15 May 24

Cidara Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results

4:22pm

8-K

EX-99.1

eg1i40nyphtjk6

3 May 24

Other Events

8:00am

8-K/A

EX-2.1

umc7ri5

29 Apr 24

Entry into a Material Definitive Agreement

4:57pm